StockData
Monopar Therapeutics logo

Monopar Therapeutics (MNPR) stock

MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$71.06−0.91 (-1.26%)

Close on Nov 17, 2026Market cap $476.97MP/E –Yield –

Monopar Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Monopar Therapeutics's price to book ratio was 3.7× on Nov 11, 2026, against 4.1× a year earlier. Over the last 5 years it ranged from 0.6× to 31.3×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.7×+0.6
2025Dec 31, 20253.1×−12.6
2024Dec 31, 202415.7×+14.9
2023Dec 29, 20230.7×−1.7
2022Dec 30, 20222.4×+0.5
2021Dec 31, 20211.9×−2.1
2020Dec 31, 20204.0×−29.3
2019Dec 31, 201933.3×–

More Monopar Therapeutics figures

See a number that looks wrong?